Amlodin:グローバル医薬品動向2014(販売量、特許、APIメーカー、治験動向など)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIDR2014279)
◆英語タイトル:Amlodin-Drug Insights,2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIDR2014279
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,000 ⇒換算¥109,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,000 ⇒換算¥218,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD3,000 ⇒換算¥327,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Amlodin:グローバル医薬品動向2014(販売量、特許、APIメーカー、治験動向など)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s pharmaceuticals report, “Amlodin – Drug Insights, 2014” provides Amlodin marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts.

Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.


• A review of the Amlodin based on information derived from company and industry-specific sources
• Coverage of the Marketed data of the Amlodin on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Schizophrenia drugs with location details
• Patent Expiry Timeline and Exclusivity Details
• Route of Synthesis of the API
• Global Forecasted Sales Figure from 2011-2015
• Qualitative and quantitative assessment of market space
• SWOT Analysis

• Evaluate the marketing status and exclusivity details of Amlodin to exploit opportunities for generic drug development opportunities.
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Amlodin.
• API intelligence over Amlodin and gaining primary intelligence over Active Ingredients manufacturers across the globe.
• Understanding the chemical route of synthesis of Amlodin.
• Uncovering opportunities in the rapidly growing the US market
• Stay ahead of competition by understanding the changing competitive landscape
• Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
• Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
• Obtain sales forecast for currently marketed drug for 2011-2015

*** レポート目次(コンテンツ)***

• Drug Overview
• Global Sales Assessment
• Product Description
• Mechanism of Action
• Pharmacodynamic Properties
• Pharmacokinetic Properties
• Marketed Details for the United States
• Marketed Details for the Europe
• Patent Information
• Patent and Exclusivity Expiry Assessment United States (US)
• Patent Numbers and Expiry Details
• Patent Details
• Route of Synthesis
• Global API Manufacturers Assessment
• The United States Drug Master File (US DMF)
• The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
• The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
• The Active Pharmaceutical Ingredient (API) Manufacturers by Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
• Generic Players
• The Pipeline Coverage
• Clinical Trials Information
• Clinical Trials by Zone
• Company Profile
• Summary
• Company Financials
• SWOT Analysis
• References
• Appendix
• Methodology
• About DelveInsight
• Contact Us
• Disclaimer

• Amlodin, Market, Global Sales (in USD), 2014
• Amlodin, Description
• Amlodin, Marketed Details the United States (US)
• Amlodin, Marketed Details the Europe (EU)
• Amlodin, Patent/Exclusivity Expiry (Year), 2014
• Amlodin, Patent Number Specific Patent Expiry (Year), 2014
• Amlodin, Patent Details
• Amlodin, Route of Synthesis
• Amlodin, the United States Drug Master File (US DMF), 2014
• Amlodin, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2014
• Amlodin, the API Manufacturers, China, 2014
• Amlodin, the API Manufacturers, India, 2014
• Amlodin, the API Manufacturers by the US DMF Status, 2014
• Amlodin, the API Manufacturers by Region, 2014
• Amlodin, the API Manufacturers by Location/Countries, 2014
• Amlodin, Generic Players, 2014
• Amlodin, Pipeline Drug Details, 2014
• Amlodin, Clinical Trials, 2014
• Amlodin, Clinical Trials by Zone, 2014
• Company Overview, 2014
• Amlodin, SWOT Analysis, 2014
• Phase III Pipeline Therapeutics, 2014

• Amlodin, Market, Global Sales (in million USD), 2014
• Amlodin, Global Sales % Change, 2014
• Amlodin, Patent/Exclusivity Expiry (Year), 2014
• Amlodin, Patent Number Specific Patent Expiry (Year), 2014
• Amlodin, Route of synthesis
• Amlodin, the API Manufacturers by the US DMF Status (%), 2014
• Amlodin, the API Manufacturers by Region, 2014
• Amlodin, the API Manufacturers by Location/Countries, 2014
• Amlodin, Generic Players, 2014
• Amlodin, Clinical Trials by Zone (%), 2014

*** レポートのキーワード ***

Cardiovascular、Amlodin、医薬品、販売量、特許、医薬品有効成分(API)メーカー、治験動向 、製薬、企業

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 酵母の世界市場:企業概要・規模・シェア・成長・動向・予測(~2025年)
    Global yeast market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Prominent factors driving the growth of this market consist of gro …
  • Silverleaf Resorts, Inc.:企業概要及びSWOT分析レポート
    This report is a crucial resource for industry executives and anyone looking to access key information about "Silverleaf Resorts, Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intel …
  • アメリカの頭蓋顎顔面固定(CMF)処置動向(~2021)
    United States Cranio Maxillofacial Fixation (CMF) Procedures Outlook to 2021 Summary GlobalData’s new report, "United States Cranio Maxillofacial Fixation (CMF) Procedures Outlook to 2021", provides key procedures data on the United States Cranio Maxillofacial Fixation Procedures. The data in the re …
  • 世界の睡眠時無呼吸診断及び治療デバイス市場(2012- 2016)
    TechNavio's analysts forecast the Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 16.37 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high prevalence of sleep apnea. The Global Sleep Apnea Diagnostic and Therapeu …
  • 世界のPVDFホモポリマー市場2016
    Notes:Production, means the output of PVDF Homopolymer Revenue, means the sales value of PVDF Homopolymer This report studies PVDF Homopolymer in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, …
  • エアコンのサウジアラビア市場
    Saudi Arabia is one of the biggest and most promising markets for air-conditioners in the GCC region, predominantly due to its geography, climate, high per capita income as well as rapid growth in population. The country had experienced decline in the air conditioner market primarily due to slump in …
  • ベーカリー及びシリアル市場展望(~2018):カナダ
    Summary The Future of the Bakery and Cereals Market in Canada to 2018 is the result of Canadean's extensive market research. The report presents detailed analysis on the Bakery and Cereals consumption trends in Canada, historic and forecast Bakery and Cereals consumption volumes and values at market …
  • 世界のイベント管理ソフトウェア市場:カンファレンス、博覧会、展示会管理
    About Event Management Software Event management software refers to a wide range of software products used in the management of professional and academic conferences, trade exhibitions and events such as continuing professional development meetings. Event management software applications include onl …
  • Knusford Bhdの企業概要及び財務/SWOT分析
    Knusford Bhd Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecast …
  • トライアルプロテーゼの世界市場動向・分析2018-2025
    Prosthesis is a man-made substitute of missing human body parts.Increasing incidences of trauma cases or accidental injuries is the primary factor responsible for the robust the growth of trial prostheses market over the forecast period. Additionally, introduction of custom made implant products and …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIDR2014279 )"Amlodin:グローバル医薬品動向2014(販売量、特許、APIメーカー、治験動向など)" (英文:Amlodin-Drug Insights,2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。